Cocrystal Pharma, Inc. (COCP) - Form 8-K Summary
Business Context and Reporting Period
Cocrystal Pharma, Inc., a Delaware corporation, filed this Current Report on Form 8-K on August 14, 2024. The filing serves to announce the Company's results of operations for the fiscal quarter ended June 30, 2024. The Company's common stock trades on The Nasdaq Capital Market under the symbol "COCP."
Financial Metrics
This Form 8-K is a notification of the release of financial results and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. The filing states that detailed results are contained in a press release furnished as Exhibit 99.1. Consequently, the filing text does not provide a clear value for any specific financial metric.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It references the press release (Exhibit 99.1) for the announcement of the quarter's operational results.
Guidance, Outlook, and Risks
The filing does not include management commentary, forward-looking guidance, specific risk factors, or contingencies within the body of the 8-K. It explicitly notes that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the specific financial results for the quarter ended June 30, 2024, by reviewing the press release attached as Exhibit 99.1 to this filing.
- Confirm the Company's liquidity position and cash burn rate, as these are not disclosed in the 8-K text itself.
- Note that the financial data in the referenced press release is furnished but not "filed" under Section 18 of the Exchange Act, which may affect liability standards.
- Check for any updates on the Company's clinical pipeline or regulatory status in the full press release, as the 8-K only announces the release of results.